Ms. Berman will be responsible for the global clinical trial program at IlluminOss, including the U.S. Lightfix trial toward securing approval for the treatment of impeding and actual fractures of the humerus in patients with metastatic bone disease, according to a news release.
Prior to joining IlluminOss, Ms. Berman was at Cordis, a Johnson & Johnson company, for nearly a decade where she held roles of increasing responsibility and oversaw various high-profile clinical research programs in the U.S., Europe and Japan.
Ms. Berman holds a master’s degree in public health from Columbia University.
More articles on executive moves:
Community Hospital Corporation names Jim Coleman SVP, Southeast hospital operations
Kauai hospital CEO Kathy Clark to retire
18 latest hospital, health system executive moves
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
